Reumatizam, Vol. 68 No. 1, 2021.
Stručni rad
https://doi.org/10.33004/reumatizam-68-1-2
Clinical manifestations of polymyalgia rheumatica – a single centre experience
Marin Petrić
; Zavod za reumatologiju i kliničku imunologiju, Klinika za unutarnje bolesti, Klinički bolnički centar Split
Daniela Marasović Krstulović
; Zavod za reumatologiju i kliničku imunologiju, Klinika za unutarnje bolesti, Klinički bolnički centar Split
Mislav Radić
; Zavod za reumatologiju i kliničku imunologiju, Klinika za unutarnje bolesti, Klinički bolnički centar Split
Katarina Borić
; Zavod za reumatologiju i kliničku imunologiju, Klinika za unutarnje bolesti, Klinički bolnički centar Split
Ivona Božić
; Zavod za reumatologiju i kliničku imunologiju, Klinika za unutarnje bolesti, Klinički bolnički centar Split
Dijana Perković
; Zavod za reumatologiju i kliničku imunologiju, Klinika za unutarnje bolesti, Klinički bolnički centar Split
Sažetak
Introduction. Polymyalgia rheumatica (PMR) is a chronic inflammatory rheumatic disease that occurs mainly in patients over the age of 50. It is characterised by pain and stiffness in the shoulder and pelvic girdle and neck. Some patients develop giant cell arteritis (GCA). The aim of our study was to present clinical characteristics of PMR patients diagnosed in the period from January 2015 to July 2020 at the Division of Rheumatology and Clinical Immunology, Split University Hospital Centre, Croatia. Materials and methods. We analysed available medical records of patients
diagnosed with PMR in accordance with the 2012 EULAR /ACR classification criteria. Methods of descriptive statistics were used in the analysis.
Forty-nine PMR patients were included in the study. The mean age of patients was 77, and 67.35% of included patients were female. Results. The most frequent PMR manifestation was joint pain, which was documented in 91.84% patients, followed by fever in 28.57% cases. GCA was diagnosed in 6 cases (12.24%). The most common comorbidities were arterial hypertension (73.47%), followed by type 2 diabetes (38.78%). In 3 cases (6.12%)
the malignant disease was diagnosed in the period of one year before and after the diagnosis of PMR. All patients received glucocorticoid therapy (GC) and remission was achieved in 45 (91.84%) cases. Conclusion. In conclusion, PMR is a disease which commonly affects the elderly, and it is successfully treated with GC. As expected, the most common symptom was joint pain, and the most common comorbidity was arterial hypertension. We did not find a higher prevalence of malignant diseases, so PMR should not be viewed as part of the paraneoplastic syndrome, which was also
confirmed by the results of the recently conducted studies.
Ključne riječi
Polymyalgia rheumatica; Comorbidity; Paraneoplastic syndrome
Hrčak ID:
280231
URI
Datum izdavanja:
11.7.2022.
Posjeta: 1.472 *